Literature DB >> 8206092

Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells.

I Correa1, L Corral, D H Raulet.   

Abstract

Several lines of evidence indicate that major histocompatibility complex class I molecules expressed by target cells can prevent natural killer cell (NK) lysis, possibly by engaging inhibitory receptors expressed by NK cells. On the other hand it is likely that NK cells must be activated to lysis by the recognition of unidentified NK target structures on target cells. To investigate the relationship between positive activation of NK cells by NK target structures versus inhibition by target cell class I molecules, we have examined various NK/target cell interactions for which the expression of inhibitory class I molecules by the target cells is known. The results suggests that specific properties of the target cell other than the absence of class I expression are necessary to activate NK-mediated lysis. Furthermore, different effector cell populations, i.e. freshly isolated versus interleukin-2 activated NK cells, differ in their capacity to kill class I-deficient lymphoblast target cells. In general, class I-deficient target cells that are resistant to direct lysis by a given NK population can be lysed by the NK cells when the reaction is mediated by antibody-dependent cellular cytotoxicity (ADCC). Most significantly, all types of NK-mediated lysis of lymphoblasts, of tumor cells and of almost any target by ADCC can be inhibited by appropriate class I gene expression in the target cell. These results suggest a model in which lysis by NK cells must be triggered by any one of a set of distinct target cell ligands, but that all of these signals can be overruled by class I-mediated inhibition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206092     DOI: 10.1002/eji.1830240613

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.

Authors:  A Cambiaggi; C Verthuy; P Naquet; F Romagné; P Ferrier; R Biassoni; A Moretta; L Moretta; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules.

Authors:  Werner Held; Anick Chalifour; Jérôme D Coudert
Journal:  Med Microbiol Immunol       Date:  2005-01-20       Impact factor: 3.402

3.  Alternatively spliced Ly-49D and H transcripts are found in IL-2-activated NK cells.

Authors:  E T Silver; J F Elliott; K P Kane
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor.

Authors:  D N Burshtyn; A M Scharenberg; N Wagtmann; S Rajagopalan; K Berrada; T Yi; J P Kinet; E O Long
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

5.  Natural killing activity in patients with spontaneous regression of malignant lymphoma.

Authors:  K Ono; M Kikuchi; N Funai; M Matsuzaki; Y Shimamoto
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

6.  Normal development and function of natural killer cells in CD3 epsilon delta 5/delta 5 mutant mice.

Authors:  V Renard; L Ardouin; M Malissen; G Milon; M Lebastard; A Gillet; B Malissen; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

7.  Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells.

Authors:  Ting Lu; Li Chen; Anthony G Mansour; Melissa J Yu; Noah Brooks; Kun-Yu Teng; Zhenlong Li; Jianying Zhang; Tasha Barr; Jianhua Yu; Michael A Caligiuri
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.426

Review 8.  Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes.

Authors:  Christian Münz
Journal:  Front Immunol       Date:  2017-11-24       Impact factor: 7.561

9.  NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses.

Authors:  Alessandra Zingoni; Michele Ardolino; Angela Santoni; Cristina Cerboni
Journal:  Front Immunol       Date:  2013-01-09       Impact factor: 7.561

10.  A reassessment of the role of B7-1 expression in tumor rejection.

Authors:  T C Wu; A Y Huang; E M Jaffee; H I Levitsky; D M Pardoll
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.